Oxymatrine

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Revision as of 17:54, November 9, 2016 by Samsara (talk | contribs) (+stub; fixed reference)

Oxymatrine is one of many quinolizidine alkaloid compounds extracted from the root of Sophora flavescens, a Chinese herb.

Oxymatrine inhibits microglial activation via TLR4.[1]

See also

References

  1. ↑ Fan, Hongguang; Li, Litao; Zhang, Xiangjian; Liu, Ying; Yang, Chenhui; Yang, Yi; Yin, Jing (2009), "Oxymatrine downregulates TLR4, TLR2, MyD88, and NF-kappaB and protects rat brains against focal ischemia", Mediators of Inflammation, 2009: 704706, doi:10.1155/2009/704706, ISSN 1466-1861, PMC 2825667, PMID 20182634
Retrieved from "https://me-pedia.org/w/index.php?title=Oxymatrine&oldid=18499"